aexeRNA Therapeutics is developing mRNA therapeutics utilizing its proprietary next generation programmable and highly potent Lipid Nanoparticle (LNP) nucleic acid delivery system. The aexLNP system was developed at George Mason University and the University of Pennsylvania.
Company Details
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://aexerna.bio/
- Keywords
- Rockville.
Aexerna Therapeutics Questions
Aexerna Therapeutics's website is https://aexerna.bio/
Aexerna Therapeutics's LinkedIn profile is https://www.linkedin.com/company/aexerna
Aexerna Therapeutics's industry is
Biotechnology Research
Aexerna Therapeutics's top competitors are
C-Reveal Therapeutics,
Cell Origin, Llc,
Newco Strategies,
Ceal Consulting,
Rna Technologies And Therapeutics,
Linden Lake Venture Capital,
Proteocell Biotechnologies Inc.,
Haag & Knight Law Pllc,
Canthevac Limited,
Conserv Bioscience.
Aexerna Therapeutics's categories are Biotechnology Research
Aexerna Therapeutics's founding year is 2020
